Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial

OBJECTIVE: The use of gonadotropin-releasing hormone agonist (GnRHa) as an alternative for human chronic gonadotropin (hCG) trigger has potential benefits, but the optimal luteal phase support (LPS) following GnRHa trigger remains to be elucidated. We aimed to investigate a new strategy (daily GnRH...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JBRA Assist Reprod
Autors principals: Salehpour, Saghar, Nazari, Leila, Hosseini, Sedighe, Azizi, Elham, Borumandnia, Nasrin, Hashemi, Teibeh
Format: Artigo
Idioma:Inglês
Publicat: Brazilian Society of Assisted Reproduction 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8312295/
https://ncbi.nlm.nih.gov/pubmed/33507722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5935/1518-0557.20200077
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars